Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Kuitunen, H. (Hanne)"'
Autor:
Kuitunen, H. (Hanne)
Diffuse large B-cell lymphoma (DLBCL) is the most common type of Non-Hodgkin´s Lymphoma (NHL). The standard treatment for DLBCL is R-CHOP chemoimmunotherapy (rituximab, cyclophosphamide, vincristine, doxorubicin and prednisone). About one -third of
Externí odkaz:
http://urn.fi/urn:isbn:9789526217154
Autor:
Poltojainen, V. (Valter), Kemppainen, J. (Janette), Keinänen, N. (Nina), Bode, M. (Michaela), Isokangas, J.-M. (Juha-Matti), Kuitunen, H. (Hanne), Nikkinen, J. (Juha), Sonkajärvi, E. (Eila), Korhonen, V. (Vesa), Tuovinen, T. (Timo), Järvelä, M. (Matti), Huotari, N. (Niko), Raitamaa, L. (Lauri), Kananen, J. (Janne), Korhonen, T. (Tommi), Tetri, S. (Sami), Kuittinen, O. (Outi), Kiviniemi, V. (Vesa)
Primary central nervous system lymphoma (PCNSL) is an aggressive brain disease where lymphocytes invade along perivascular spaces of arteries and veins. The invasion markedly changes (peri)vascular structures but its effect on physiological brain pul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::d1c1746bcb8f3dbdfb13828649d91ade
http://urn.fi/urn:nbn:fi-fe2023062759498
http://urn.fi/urn:nbn:fi-fe2023062759498
Autor:
Chan, M. C. (Mikko C.), Savela, J. (Janette), Ollikainen, R. K. (Riina K.), Teppo, H.-R. (Hanna-Riikka), Miinalainen, I. (Ilkka), Pirinen, R. (Risto), Kari, E. J. (Esa J. M.), Kuitunen, H. (Hanne), Turpeenniemi-Hujanen, T. (Taina), Kuittinen, O. (Outi), Kuusisto, M. E. (Milla E. L.)
DLBCL is the most common type of non-Hodgkin lymphoma with a substantial group of patients suffering a poor prognosis. Therefore more specific markers are required for better understanding of disease biology and treatment. This study demonstrates tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::f46fa63eb7fec776e178f8b7eb0b92b2
http://urn.fi/urn:nbn:fi-fe2021041610781
http://urn.fi/urn:nbn:fi-fe2021041610781
Autor:
Ollikainen, R. K. (Riina K.), Kotkaranta, P. H. (Pyry H.), Kemppainen, J. (Janette), Teppo, H.-R. (Hanna-Riikka), Kuitunen, H. (Hanne), Pirinen, R. (Risto), Turpeenniemi-Hujanen, T. (Taina), Kuittinen, O. (Outi), Kuusisto, M. E. (Milla E.L.)
Although treatment for diffuse large B-cell lymphoma (DLBCL) has taken some notable steps in the 2000s, there are still subgroups of patients suffering from high mortality and relapse rates. To further improve treatment outcomes, it is essential to d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::821ba648a87b1d15122bcf576ead9dcc
http://urn.fi/urn:nbn:fi-fe2021122162825
http://urn.fi/urn:nbn:fi-fe2021122162825
Autor:
Tokola, S. (Susanna), Kuitunen, H. (Hanne), Turpeenniemi-Hujanen, T. (Taina), Kuittinen, O. (Outi)
The application of positron emission tomography (PET)-computed tomography (CT) in treatment response evaluation has increased in diffuse large B-cell lymphoma (DLBCL), although its predictive value is controversial. We retrospectively analyzed the ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::ac9ef11a9a9c7ea190bb4e083d952ac5
http://urn.fi/urn:nbn:fi-fe2021061436816
http://urn.fi/urn:nbn:fi-fe2021061436816
Autor:
Tokola, S. (Susanna), Kuitunen, H. (Hanne), Turpeenniemi-Hujanen, T. (Taina), Kuittinen, O. (Outi)
Bulky and residual tumor are considered to increase the risk of relapse in diffuse large B‐cell lymphoma (DLBCL) patients. Radiotherapy is conventionally used to reduce the risk, but the evidence is controversial. We performed a retrospective analy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::617f51cddb480cdf5f683f1880b6a944
http://urn.fi/urn:nbn:fi-fe2020042822874
http://urn.fi/urn:nbn:fi-fe2020042822874
Autor:
Turunen, A. (Antti), Partanen, A. (Anu), Valtola, J. (Jaakko), Ropponen, A. (Antti), Siitonen, T. (Timo), Kuittinen, O. (Outi), Kuitunen, H. (Hanne), Putkonen, M. (Mervi), Sankelo, M. (Marja), Keskinen, L. (Leena), Savolainen, E. (Eeva‐Riitta), Pyörälä, M. (Marja), Kuittinen, T. (Taru), Silvennoinen, R. (Raija), Penttilä, K. (Karri), Sikiö, A. (Anu), Vasala, K. (Kaija), Mäntymaa, P. (Pentti), Pelkonen, J. (Jukka), Varmavuo, V. (Ville), Jantunen, E. (Esa)
Background: Autologous stem cell transplantation is an established treatment option for patients with multiple myeloma (MM) or non‐Hodgkinʼs lymphoma (NHL). Study design and methods: In this prospective multicenter study, 147 patients with MM were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::2ce12e81de33350b9d630814a00c0d82
http://urn.fi/urn:nbn:fi-fe2020091769957
http://urn.fi/urn:nbn:fi-fe2020091769957
Autor:
Prusila, R. E. (Roosa E. I.), Sorigue, M. (Marc), Jauhiainen, J. (Jyrki), Mercadal, S. (Santiago), Postila, A. (Aleksi), Salmi, P. (Petteri), Tanhua, T. (Taru), Tikkanen, S. (Susanna), Kakko, S. (Sakari), Kuitunen, H. (Hanne), Pollari, M. (Marjukka), Nystrand, I. (Ilja), Kuusisto, M. E. (Milla E. L.), Vasala, K. (Kaija), Jantunen, E. (Esa), Korkeila, E. (Eija), Karihtala, P. (Peeter), Sancho, J. (Juan‐Manuel), Turpeenniemi‐Hujanen, T. (Taina), Kuittinen, O. (Outi)
Publikováno v:
British Journal of Haematology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Follicular lymphoma (FL) is the most common indolent lymphoma. Currently there are many comparable treatment options available for FL. When selecting the most optimal therapy it is important to consider possible late effects of the treatment as well
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::207fb7a1e225966ac134639fc2db5fd4
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3184
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3184
Autor:
Tokola, S. (Susanna)
Approximately 1,300 patients develop non-Hodgkin lymphoma (NHL) in Finland each year. Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of NHL; in 2018, a total of 661 patients were identified with this disease in Finland. DLBCL is one
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::344a41eccfe6ec44b27a4476a000ae47
http://urn.fi/urn:isbn:9789526230542
http://urn.fi/urn:isbn:9789526230542